Correlation Engine 2.0
Clear Search sequence regions


  • brain (1)
  • cognitive (1)
  • factor (5)
  • family (2)
  • inflammasomes (2)
  • leukemia (1)
  • long term effect (1)
  • mice (1)
  • NFATc1 (3)
  • NFI (2)
  • NLR (2)
  • NLRP3 (2)
  • PIM1 (3)
  • plasmalogen (5)
  • products (2)
  • provirus (1)
  • Pyrin (2)
  • receptor (3)
  • scallop (3)
  • signal (1)
  • STAT3 (2)
  • t cells (1)
  • Sizes of these terms reflect their relevance to your search.

    A strong relationship between Alzheimer's disease (AD) and vascular dysfunction has been the focus of increasing attention in aging societies. In the present study, we examined the long-term effect of scallop-derived plasmalogen (sPlas) on vascular remodeling-related proteins in the brain of an AD with cerebral hypoperfusion (HP) mouse model. We demonstrated, for the first time, that cerebral HP activated the axis of the receptor for advanced glycation endproducts (RAGE)/phosphorylated signal transducer and activator of transcription 3 (pSTAT3)/provirus integration site for Moloney murine leukemia virus 1 (PIM1)/nuclear factor of activated T cells 1 (NFATc1), accounting for such cerebral vascular remodeling. Moreover, we also found that cerebral HP accelerated pSTAT3-mediated astrogliosis and activation of the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) inflammasome, probably leading to cognitive decline. On the other hand, sPlas treatment attenuated the activation of the pSTAT3/PIM1/NFATc1 axis independent of RAGE and significantly suppressed NLRP3 inflammasome activation, demonstrating the beneficial effect on AD. Copyright © 2024 Elsevier B.V. All rights reserved.

    Citation

    Yun Zhai, Ryuta Morihara, Tian Feng, Xinran Hu, Yusuke Fukui, Zhihong Bian, Yuting Bian, Haibo Yu, Hongming Sun, Mami Takemoto, Yumiko Nakano, Taijun Yunoki, Ying Tang, Hiroyuki Ishiura, Toru Yamashita. Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer's disease with cerebral hypoperfusion. Brain research. 2024 Apr 01;1828:148790

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38272156

    View Full Text